GMaP Goals and Electives
What are the goals of the Geographical Management of Cancer Health Disparities Program (GMaP)?
- Advance the science of cancer health disparities in these regions.
- Contribute to the next generation of cancer health disparities researchers.
- Achieve measurable reductions in cancer health disparities in these regions.
What is an elective?
To ensure that network hubs have the greatest impact on cancer health disparities research and resource capacity, GMaP uses four electives, around which each region in the GMaP network is required to build infrastructure:
- BMaP (Biospecimen science): Seeks to create unique, centralized, public resources for multiethnic biobanking/biospecimens, and ensures high-quality human biospecimens are available for cancer research that examines the cultural differences of diverse communities in specific regions.
- IMaP (Bioinformatics): Increases the bioinformatics capabilities and infrastructure within participating institutions, creates an interface with caBIG (cancer Biomedical Informatics Grid), and implements caBIG applications relevant to GMaP activities around cancer health disparities.
- CTMaP (Clinical trials): Improves the recruitment and retention of cancer patients from racial/ethnic groups and other underserved populations in medical research and/or clinical trials.
- EMaP (Emerging technologies): Identifies and develops emerging technologies in the areas of molecular diagnostics, molecular imaging, nanotechnology, and targeted therapeutics, and educates principal investigators on their applications for addressing cancer health disparities research and training.